5 July 2022
Cells | Top Cited Papers in 2020 in the Section “Cell Signaling”
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
1. “Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy”
by Ufuk Degirmenci et al.
Cells 2020, 9(1), 198; https://doi.org/10.3390/cells9010198
Available online: https://www.mdpi.com/2073-4409/9/1/198
2. “Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial–Mesenchymal Transition”
by Wook Jin
Cells 2020, 9(1), 217; https://doi.org/10.3390/cells9010217
Available online: https://www.mdpi.com/2073-4409/9/1/217
3. “Targeting GSK3 and Associated Signaling Pathways Involved in Cancer”
by Przemysław Duda et al.
Cells 2020, 9(5), 1110; https://doi.org/10.3390/cells9051110
Available online: https://www.mdpi.com/2073-4409/9/5/1110
4. “Role of TGF-β in Skin Chronic Wounds: A Keratinocyte Perspective”
by Sergio Liarte et al.
Cells 2020, 9(2), 306; https://doi.org/10.3390/cells9020306
Available online: https://www.mdpi.com/2073-4409/9/2/306
5. “The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer”
by Manel B. Hammouda et al.
Cells 2020, 9(4), 857; https://doi.org/10.3390/cells9040857
Available online: https://www.mdpi.com/2073-4409/9/4/857
6. “Reactive Oxygen Species and Redox Signaling in Chronic Kidney Disease”
by Maria V. Irazabal et al.
Cells 2020, 9(6), 1342; https://doi.org/10.3390/cells9061342
Available online: https://www.mdpi.com/2073-4409/9/6/1342
7. “Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases”
by Wiwin Is Effendi et al.
Cells 2020, 9(3), 785; https://doi.org/10.3390/cells9030785
Available online: https://www.mdpi.com/2073-4409/9/3/785
8. “Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance”
by József Dudás et al.
Cells 2020, 9(2), 428; https://doi.org/10.3390/cells9020428
Available online: https://www.mdpi.com/2073-4409/9/2/428
9. “GSK3: A Kinase Balancing Promotion and Resolution of Inflammation”
by Leonie Hoffmeister et al.
Cells 2020, 9(4), 820; https://doi.org/10.3390/cells9040820
Available online: https://www.mdpi.com/2073-4409/9/4/820
10. “Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer”
by Simona D’Aguanno et al.
Cells 2020, 9(5), 1287; https://doi.org/10.3390/cells9051287
Available online: https://www.mdpi.com/2073-4409/9/5/1287